INCY

HOLD

Incyte Corporation

Healthcare · Rank #15 · Analyzed Apr 20, 2026

$97.82

Current Price

$861.11

Intrinsic Value

0.0%

Upside/Downside

10/10

Score

5/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$20.77

Base (IV)$861.11

High$1333.43

Entry Points

Conservative$20.77

Moderate$440.94

Aggressive$861.11

⚠️ Warnings

Upside capped: raw 1263% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity29.9% → 1.0/1.0

Debt LevelD/E 1 → 1.0/1.0

Revenue QualityGrowth 19.2%, margin Δ+22.8% +recovery → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins25.0% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.